Anna R Chang MD
Diabetes, Lipid Metabolism
Medical Director of Endocrinology and Diabetes Services
Join to View Full Profile
2700 Grant StSuite 200Concord, CA 94520
Phone+1 925-677-0515
Fax+1 925-677-0527
Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Diego) Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2002 - 2004- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1998 - 2001
University of California San Diego School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 1999 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2015 Oct 20
- A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy Start of enrollment: 2019 Feb 14
- A Study of LY3209590 in Participants With Type 1 Diabetes Start of enrollment: 2020 Jul 06
- Join now to see all
Publications & Presentations
PubMed
- 40 citationsEvaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.Satish K. Garg, David R. Liljenquist, Bruce W. Bode, Mark P. Christiansen, Timothy S. Bailey
Diabetes Technology & Therapeutics. 2021-09-09 - 19 citationsDose-dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial.Claire Baker, Suman Wason, Phillip Banks, Sangeeta Sawhney, Anna Chang
Diabetes, Obesity & Metabolism. 2019-11-01 - 86 citationsA Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II.Mark P. Christiansen, Leslie J. Klaff, Ronald L. Brazg, Anna R Chang, Carol J. Levy
Diabetes Technology & Therapeutics. 2018-01-30
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
